Your browser doesn't support javascript.
loading
Recent developments in understanding RIG-I's activation and oligomerization.
Sikorska, Justyna; Wyss, Daniel F.
Afiliação
  • Sikorska J; Merck & Co., Inc., Rahway, NJ, USA.
  • Wyss DF; Merck & Co., Inc., Rahway, NJ, USA.
Sci Prog ; 107(3): 368504241265182, 2024.
Article em En | MEDLINE | ID: mdl-39091074
ABSTRACT
Insights into mechanisms driving either activation or inhibition of immune response are crucial in understanding the pathology of various diseases. The differentiation of viral from endogenous RNA in the cytoplasm by pattern-recognition receptors, such as retinoic acid-inducible gene I (RIG-I), is one of the essential paths for timely activation of an antiviral immune response through induction of type I interferons (IFN). In this mini-review, we describe the most recent developments centered around RIG-I's structure and mechanism of action. We summarize the paradigm-changing work over the past few years that helped us better understand RIG-I's monomeric and oligomerization states and their role in conveying immune response. We also discuss potential applications of the modulation of the RIG-I pathway in preventing autoimmune diseases or induction of immunity against viral infections. Overall, our review aims to summarize innovative research published in the past few years to help clarify questions that have long persisted around RIG-I.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Proteína DEAD-box 58 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Proteína DEAD-box 58 Idioma: En Ano de publicação: 2024 Tipo de documento: Article